Search

Your search keyword '"Dumont, Martine"' showing total 583 results

Search Constraints

Start Over You searched for: Author "Dumont, Martine" Remove constraint Author: "Dumont, Martine"
583 results on '"Dumont, Martine"'

Search Results

1. Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

2. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

3. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

4. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

5. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.

6. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

7. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

8. Association analysis identifies 65 new breast cancer risk loci

9. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

10. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.

11. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

12. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

13. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.

14. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

15. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

16. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.

17. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.

18. RAD51B in Familial Breast Cancer.

19. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects

20. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

21. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.

22. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

23. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

24. Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

25. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

26. Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

27. Supplementary Tables 1-9 from Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

28. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

29. Uncovering the contribution of moderate-penetrance susceptibility genes to breast cancer by whole-exome sequencing and targeted enrichment sequencing of candidate genes in women of European ancestry

30. Exome sequencing identifies novel susceptibility genes and defines the contribution of coding variants to breast cancer risk.

31. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

32. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

33. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

34. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

36. RAD51 135G C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

37. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

38. Influence of the angiotensin-converting enzyme gene insertion/deletion polymorphism on lipoprotein/lipid response to gemfibrozil

42. Liste des auteurs

43. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

45. Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

46. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

49. Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control

Catalog

Books, media, physical & digital resources